Scleritis: Differentiating infectious from non-infectious entities
Somasheila I Murthy1, Swapnali Sabhapandit2, S Balamurugan3, Pranesh Subramaniam3, Maite Sainz-de-la-Maza4, Manisha Agarwal5, Carlos Parvesio6
1 The Cornea Institute, L V Prasad Eye Institute, Hyderabad, Telangana, India 2 NeoRetina Eye Care Institute, Centre for Sight, Hyderabad, Telangana, India 3 Department of Uvea, Aravind Eye Hospital, Pondicherry, India 4 Hospital Clinic of Barcelona, Spain 5 Dr. Shroff's Charity Eye Hospital, New Delhi, India 6 Consultant Ophthalmologist, Moorfields Eye Hospital, Senior Lecturer, Biomedical Research Centre, Institute of Ophthalmology UCL Moorfields Eye Hospital, London, United Kingdom
Correspondence Address:
Dr. Somasheila I Murthy Head of Service, Department of Cornea, Kallam Anji Reddy Campus, The Cornea Institute, L V Prasad Eye Institute, LV Prasad Marg, Banjara Hills, Hyderabad - 500 034, Telangana India
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/ijo.IJO_2032_20
|
Scleritis is a rare painful ocular disorder, associated with severe ocular pain and tissue destruction. Although a majority of these cases are immune mediated and at least half of these are associated with systemic immune-mediated diseases, a smaller minority are due to infections of the sclera. The two conditions closely mimic each other, and a thorough knowledge of the subtle differences is necessary in order to reach a timely diagnosis. Diagnostic delay can lead to a poor outcome both due to the destruction caused by the uncontrolled infection and also due to propagation of the infection with the use of corticosteroids which may have been started for presumed immune mediated scleritis. In this review, we present the clinical features, etiological agents, and the differentiating features between immune and infectious scleritis. We also present diagnostic and management guidelines for managing scleral infection.
|